These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29914957)

  • 1. Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs.
    Bassi MR; Sempere RN; Meyn P; Polacek C; Arias A
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
    Kim JA; Seong RK; Kumar M; Shin OS
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides.
    Sempere RN; Arias A
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favipiravir elicits antiviral mutagenesis during virus replication in vivo.
    Arias A; Thorne L; Goodfellow I
    Elife; 2014 Oct; 3():e03679. PubMed ID: 25333492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin.
    Baz M; Goyette N; Griffin BD; Kobinger GP; Boivin G
    Antivir Ther; 2017; 22(7):613-618. PubMed ID: 28694390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
    Pires de Mello CP; Tao X; Kim TH; Vicchiarelli M; Bulitta JB; Kaushik A; Brown AN
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis.
    Escribano-Romero E; Jiménez de Oya N; Domingo E; Saiz JC
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favipiravir inhibits in vitro Usutu virus replication and delays disease progression in an infection model in mice.
    Segura Guerrero NA; Sharma S; Neyts J; Kaptein SJF
    Antiviral Res; 2018 Dec; 160():137-142. PubMed ID: 30385306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery.
    Baker C; Xie X; Zou J; Muruato A; Fink K; Shi PY
    EBioMedicine; 2020 Jul; 57():102838. PubMed ID: 32574959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
    Cai L; Sun Y; Song Y; Xu L; Bei Z; Zhang D; Dou Y; Wang H
    Arch Virol; 2017 Sep; 162(9):2847-2853. PubMed ID: 28597088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favipiravir can evoke lethal mutagenesis and extinction of foot-and-mouth disease virus.
    de Avila AI; Moreno E; Perales C; Domingo E
    Virus Res; 2017 Apr; 233():105-112. PubMed ID: 28322918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
    Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
    Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare haplotype load as marker for lethal mutagenesis.
    Gregori J; Soria ME; Gallego I; Guerrero-Murillo M; Esteban JI; Quer J; Perales C; Domingo E
    PLoS One; 2018; 13(10):e0204877. PubMed ID: 30281674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
    Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
    Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ribavirin on the replication and genetic stability of porcine reproductive and respiratory syndrome virus.
    Khatun A; Shabir N; Yoon KJ; Kim WI
    BMC Vet Res; 2015 Feb; 11():21. PubMed ID: 25890207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.
    Yu Y; Deng YQ; Zou P; Wang Q; Dai Y; Yu F; Du L; Zhang NN; Tian M; Hao JN; Meng Y; Li Y; Zhou X; Fuk-Woo Chan J; Yuen KY; Qin CF; Jiang S; Lu L
    Nat Commun; 2017 Jul; 8():15672. PubMed ID: 28742068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-
    Merino-Ramos T; Jiménez de Oya N; Saiz JC; Martín-Acebes MA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
    Tong X; Smith J; Bukreyeva N; Koma T; Manning JT; Kalkeri R; Kwong AD; Paessler S
    Antiviral Res; 2018 Jan; 149():34-40. PubMed ID: 29126899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals.
    Lanko K; Eggermont K; Patel A; Kaptein S; Delang L; Verfaillie CM; Neyts J
    Antiviral Res; 2017 Sep; 145():82-86. PubMed ID: 28736077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.